Vitamin K and Cognition in Coronary Heart Disease (NutriCog)
ConditionCoronary Heart Disease
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorMontreal Heart Institute
About this trial
The purpose of this pilot study is to obtain a preliminary assessment of the effect of VK supplementation on cognitive performance and vascular function in adults with stable Coronary Heart Disease (CHD)
Eligibility criteria
Qualifiers
Men and women
Age 60 years and older
Medically documented stable Coronary Heart Disease (CHD)
Daily dietary intakes of phylloquinone <150 mcg
Disqualifiers
Recent acute coronary syndrome (<3 months) or recent coronary revascularization (bypass surgery or percutaneous coronary intervention, <3 months)
Known left ventricular dysfunction (LVEF < 40%) or chronic heart failure
Recent modification of medication (<2 weeks)
Warfarin (Coumadin) use
Trial design
Treatments tested in this trial
- Vitamin K
- Placebo
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov